Liver computed tomographic perfusion for monitoring the early therapeutic response to sorafenib in advanced hepatocellular carcinoma patients
Conclusions: CTP might be applied to evaluate therapeutic effects of sorafenib in advanced HCC, where HAF could potentially serve as imaging biomarkers for monitoring early therapeutic effects after treatment.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Xiaojun Shen Dong Wu Min Tang Huichuan Sun Yuan Ji Cheng Huang Mengsu Zeng Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | CT Scan | Hepatocellular Carcinoma | Liver | Liver Cancer | Men | Perfusion | PET Scan | Study | Urology & Nephrology